Rocket One Inc. Other General and Administrative Expense
Rocket One Inc. (RKTO) reported Other General and Administrative Expense of $326.88 thousand for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OtherGeneralAndAdministrativeExpense · last filed 2024-11-12
- Rocket One Inc. other general and administrative expense for the quarter ending 2024-03-31 was $326.88K.
- Rocket One Inc. other general and administrative expense for the quarter ending 2023-12-31 was $559.85K.
- Rocket One Inc. other general and administrative expense for the quarter ending 2023-09-30 was $67.10K.
- Rocket One Inc. other general and administrative expense for the quarter ending 2023-06-30 was $46.17K.
- Rocket One Inc. other general and administrative expense for fiscal 2023 was $1.00M.
| Period end | Other General and Administrative Expense 3 month | Other General and Administrative Expense 6 month | Other General and Administrative Expense 9 month | Other General and Administrative Expense 12 month |
|---|---|---|---|---|
| 2024-03-31 | $326.88K 10-Q · filed 2024-05-14 | $886.73K derived: sum of 2 quarters · filed 2024-05-14 | $953.83K derived: sum of 3 quarters · filed 2024-11-12 | $1.00M derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-12-31 | $559.85K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $626.95K derived: sum of 2 quarters · filed 2024-11-12 | $673.12K derived: sum of 3 quarters · filed 2024-11-12 | $1.00M 10-K · filed 2024-03-28 |
| 2023-09-30 | $67.10K 10-Q · filed 2024-11-12 | $113.27K derived: sum of 2 quarters · filed 2024-11-12 | $440.15K 10-Q · filed 2024-11-12 | |
| 2023-06-30 | $46.17K 10-Q · filed 2024-08-09 | $373.05K 10-Q · filed 2024-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |